Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease
DOI:
https://doi.org/10.46243/jst.2023.v8.i08.pp1-17Keywords:
Hypertension, Diabetes, Liver, Kidney, LipidAbstract
Introduction: Lipotoxicity is a result of hyperlipidemia. Lipid and cholesterol buildup in the arteries causes atherosclerosis, which damages key organs including the heart and kidneys and causes cardiovascular disorders. Methods: Fasting blood samples were collected and tested using an automated biochemistry analyzer for dyslipidemia screening. Five participant groups—those with hypertension, diabetes, kidney disease, or liver disease—as well as a control group of people without these conditions—were used to collect the data. There were 101 patients in the study, with at least 20 volunteers in each group ranging in age from 18 to 70. The data were statistically compared using the independent two-sample t-test. Results: Hypertension and diabetes associated participants had an increased mean of low-density lipoprotein, very low-density lipoprotein, total cholesterol, and triglycerides levels than control (p<0.05). These were likewise higher in kidney disease patients compared to the control group (p<0.05). High-density lipoprotein levels did not change significantly in these groups. In liver disease patients mean triglycerides and very lowdensity lipoprotein levels were found significantly higher when compared to the control group (p<0.05). Mean high density lipoprotein levels in individuals with liver disease reveal a significant drop when compared to the control group, with a 90% confidence level. Conclusion: A link between hyperlipidemia and patients with hypertension, diabetes, liver disease, and renal disease was observed. Diabetes and high blood pressure were present in the majority of patients with renal and hepatic dysfunction.
References
Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens. 2010 Jul;19(4):393-402. doi: 10.1097/ MNH.0b013e32833aa4ac, PMID 20489613
Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011 Dec;13(6):544-52. doi: 10.1007/s11886-011- 0220-3, PMID 21968696
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi: 10.1186/s12933-018-0762- 4, PMID 30170598
Jiang ZG, Robson SC, Yao Z. Lipoprotein metabolism in non-alcoholic fatty liver disease. J Biomed Res. 2013 Jan;27(1):1-13. doi: 10.7555/ JBR.27.20120077, PMID 23554788
Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. doi: 10.1186/ s12902-022-00980-1, PMID 35287643
Przybyszewski EM, Targher G, Roden M, Corey KE. Nonalcoholic fatty liver disease and cardiovascular disease. Clin Liver Dis. 2021;17(1):19-22. doi: 10.1002/cld.1017, PMID 33552481
Choudhury D, Tuncel M, Levi M. Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol. 2009 Nov;29(6):610-
doi: 10.1016/j.semnephrol.2009.07.006, PMID 20006793
Tao M, Wang HP, Sun J, Tian J. Progress of research on dyslipidemia accompanied by nephrotic syndrome. Chronic Dis Transl Med. 2020 Sep;6(3):182-7. doi: 10.1016/j. cdtm.2020.03.002, PMID 32885154
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-52. doi: 10.1016/ S0140-6736(13)60595-4, PMID 23727170
Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol. 2012;56(6):1299-304. doi: 10.1016/j. jhep.2011.12.030, PMID 22314431
Chen S, Cheng W. Relationship between lipid profiles and hypertension: A cross-sectional study of 62,957 Chinese adult males. Front Public Health. 2022; 10:895499. doi: 10.3389/ fpubh.2022.895499, PMID 35664125
Bønaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromsø study. Circulation. 1991;83(4, Apr):1305-14. doi: 10.1161/01.CIR.83.4.1305, PMID 2013148
Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016 Mar;5(3):e003053. doi: 10.1161/ JAHA.115.003053, PMID 27016576
Saki SA, Nessa A, Salma MU, Begum A. Relationship of HDL-C and triglyceride with hypertension in adult men. Mymensingh Med J. Apr 01 2019;28(2):298-301. PMID 31086141
Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep. 2013 Feb;15(1):59-
doi: 10.1007/s11906-012-0323-2, PMID 23242734
Mänttäri M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension. 1995;26(4):670-5. doi: 10.1161/01.hyp.26.4.670, PMID 7558229
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):293-Priyadarshini Roy, Lakshmi Nair: Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease
doi: 10.1046/j.1523-1755.2000.00165.x, PMID 10886574
Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G et al. Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chronic kidney disease. J Clin Transl Endocrinol. 2016 Dec; 6:8-14. doi: 10.1016/j.jcte.2016.08.002, PMID 29067238
Zhang H, Shi S, Zhao XJ, Wang JK, Liu ZW, Liu FQ et al. Association between the lipid profile and renal dysfunction in the heart failure patients. Kidney Blood Press Res. 2019;44(1):52-61). doi: 10.1159/000498834, PMID 30808836
Lapinleimu H, Viikari J, Jokinen E, Routi T, Salo P, Hollo O et al. Cholesterol measurement by reflotron dry chemistry in infants, children and adults. Scand J Clin Lab Invest. 1994 Feb;54(1):61-
doi: 10.3109/00365519409086511, PMID 8171273
Moestrup SK, Nielsen LB. Nielsen et al. The role of the kidney in lipid metabolism. Curr Opin Lipidol. Jun 2005;16(3):301-6. doi: 10.1097/01. mol.0000169350.45944.d4, PMID 15891391
National kidney foundation. Available from: https://www.kidney.org/news/newsroom/ factsheets/High-Blood-Pressure-and-CKD
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595-601. doi: 10.1161/01.HYP.0000145180.38707.84, PMID 15452024
Wang T, Visentin M, Gerd A, Xianjun F, Wang Z, Zhibo G et al. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11(4),722:11040722. doi: 10.3390/nu
Bhowmik B, Siddiquee T, Omsland KT. Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population (Int J Environ Res Public Health.2018. Sep 1944;15(9)
Sadeghi E, Hosseini SM, Vossoughi M, Aminorroaya A, Amini M. Association of lipid profile with Type 2 diabetes in first-degree relatives: A 14-year follow-up study in Iran. Diabetes Metab Syndr Obes. 2020; 13:2743-50. doi: 10.2147/DMSO.S259697, PMID 32801820
Indu KC, Deo RK, Roka K, Singh P, Alam Z. Study of Lipid profile in patients with Diabetes Mellitus presenting at tertiary referral center in Nepal, MJSBH vol. Vol. 21(1, Jan-Jun); 2022
Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol. 2011 Nov;5(6):1572-
doi: 10.1177/193229681100500634, PMID 22226280
The truth about triglycerides, health encyclopedia. University of Rochester Medical center. Available from: https://www.urmc.rochester. edu/encyclopedia/content.aspx?contenttypeid =56&contentid=2967
Mengyang H, Ling Y, Lu Z, Liu Y, Gu P, Shao J et al. Contribution and interaction of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: A cross-sectional study. J Diabetes Investig. 2019 Jan;10(1):131-8. Published online 2018 May 24. doi: 10.1111/ jdi.12856, PMID 29694714
Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab. 2013 Aug;24(8). Published online May 27:391-7:391-7. doi: 10.1016/j. tem.2013.04.001, PMID 23721961
Som K, Swaika BC, Pramanik S, Chakraborty P, Gantait K. Lipid profile in alcoholic and nonalcoholic patients of chronic liver disease–A comparative and analytical study in a Ruralbased tertiary Care Center. J Assoc Phys India. 2019;67(4):22-4. PMID 31311213 Vol
Mahaling DU, Basavaraj MM, Bika AJ. Comparison of lipid profile in different grades of nonalcoholic fatty liver disease diagnosed on ultrasound. Asian Pac J Trop Biomed. 2013;3(11, Nov):907-12. doi: 10.1016/S2221-1691(13)60177-X
Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the Persian Guilan cohort study (PGCS), Iran. J Fam Med Prim Care. 2019 Mar;8(3):923-8. doi: 10.4103/jfmpc. PMID 31041226
Kumari R, Kumar PS, Jana D. Dyslipidaemia in non-alcoholic fatty liver disease. IJSR. 2021:24-
doi: 10.36106/ijsr/9739450
Cuenza LR, Razon TLJ, Dayrit JC. Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients. J Cardiovasc Thorac Res. 2017;9(2):85-9. doi: 10.15171/ jcvtr.2017.14, PMID 28740627. Priyadarshini Roy, Lakshmi Nair: Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease
Novakovic T, Mekic M, Smilic L, Smilic T, Inić-Kostic B, Jovicevic L et al. Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. Med Arch. 2014 Feb;68(1):22-
doi: 10.5455/medarh.2014.68.22-26, PMID 24783906
Published
How to Cite
Issue
Section
